The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications.
Rothwell
N
N
School of Biological Sciences, University of Manchester, Manchester M13 9PT, United Kingdom. Nancy.Rothwell@man.ac.uk
Allan
S
S
Toulmond
S
S
D000208:Acute Disease; D000818:Animals; D017209:Apoptosis; D001921:Brain / Q000276:immunology; D020170:Caspase 1; D002561:Cerebrovascular Disorders / Q000276:immunology* / Q000628:therapy; D003546:Cysteine Endopeptidases / Q000378:metabolism; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1 / Q000037:antagonists & inhibitors / Q000276:immunology*; D019636:Neurodegenerative Diseases / Q000276:immunology* / Q000628:therapy; D009474:Neurons / Q000166:cytology; D012795:Sialoglycoproteins / Q000627:therapeutic use
C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1; D012795:Sialoglycoproteins; D003546:Cysteine Endopeptidases; D020170:Caspase 1